BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1426 related articles for article (PubMed ID: 14671650)

  • 21. Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience.
    Dawidowska M; Jółkowska J; Szczepański T; Derwich K; Wachowiak J; Witt M
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):409-18. PubMed ID: 19043668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia.
    Meleshko AN; Lipay NV; Stasevich IV; Potapnev MP
    Exp Oncol; 2005 Dec; 27(4):319-24. PubMed ID: 16404354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
    Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
    Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
    Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
    Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases.
    Thériault C; Galoin S; Valmary S; Selves J; Lamant L; Roda D; Rigal-Huguet F; Brousset P; Delsol G; Al Saati T
    Mod Pathol; 2000 Dec; 13(12):1269-79. PubMed ID: 11144922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pattern of clonal immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Chinese adult acute lymphoblastic leukemia patients.
    Yao L; Chen Z; Cen J; Liang J; Feng Y; He J; Qi X; Shen H
    Leuk Res; 2008 Nov; 32(11):1735-40. PubMed ID: 18456325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
    Guggemos A; Eckert C; Szczepanski T; Hanel C; Taube T; van der Velden VH; Graf-Einsiedel H; Henze G; Seeger K
    Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma.
    Payne K; Wright P; Grant JW; Huang Y; Hamoudi R; Bacon CM; Du MQ; Liu H
    Br J Haematol; 2011 Oct; 155(1):84-92. PubMed ID: 21790530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
    van Krieken JH; Langerak AW; Macintyre EA; Kneba M; Hodges E; Sanz RG; Morgan GJ; Parreira A; Molina TJ; Cabeçadas J; Gaulard P; Jasani B; Garcia JF; Ott M; Hannsmann ML; Berger F; Hummel M; Davi F; Brüggemann M; Lavender FL; Schuuring E; Evans PA; White H; Salles G; Groenen PJ; Gameiro P; Pott Ch; Dongen JJ
    Leukemia; 2007 Feb; 21(2):201-6. PubMed ID: 17170732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genotypic analysis in primary cutaneous lymphomas using the standardized BIOMED-2 polymerase chain reaction protocols].
    Gallardo F; Bellosillo B; Serrano S; Pujol RM
    Actas Dermosifiliogr; 2008 Oct; 99(8):608-20. PubMed ID: 19080892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia.
    Poopak B; Saki N; Purfatholah AA; Najmabadi H; Mortazavi Y; Arzanian MT; Khosravipour G; Haghnejad F; Salari F; Shahjahani M
    Hematology; 2014 Jul; 19(5):259-66. PubMed ID: 24620952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GeneScanning analysis of Ig/TCR gene rearrangements to detect clonality in canine lymphomas.
    Gentilini F; Calzolari C; Turba ME; Bettini G; Famigli-Bergamini P
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):47-56. PubMed ID: 18963006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.
    Sandberg Y; van Gastel-Mol EJ; Verhaaf B; Lam KH; van Dongen JJ; Langerak AW
    J Mol Diagn; 2005 Oct; 7(4):495-503. PubMed ID: 16237219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
    Szczepański T; Beishuizen A; Pongers-Willemse MJ; Hählen K; Van Wering ER; Wijkhuijs AJ; Tibbe GJ; De Bruijn MA; Van Dongen JJ
    Leukemia; 1999 Feb; 13(2):196-205. PubMed ID: 10025893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of BIOMED- 2 standardized Ig gene rearrangement system in multiple myeloma].
    Ai X; Wang X; Wang B; Chen S; Wang J; Li Q; An G; Ru K
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):918-21. PubMed ID: 26632463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of T-cell receptor gamma-gene rearrangement in lymphoproliferative disorders using polymerase chain reaction].
    Nagy M; Fehér K; László T; Szomor A; Losonczy H; Kelényi G; Matolcsy A
    Orv Hetil; 1999 Oct; 140(44):2441-4. PubMed ID: 10573987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.